Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition).
Trichophyton indotineae
diagnosis
prevention and control
resistant dermatophytes
treatment
Journal
Mycoses
ISSN: 1439-0507
Titre abrégé: Mycoses
Pays: Germany
ID NLM: 8805008
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
received:
13
07
2024
accepted:
18
07
2024
medline:
9
9
2024
pubmed:
9
9
2024
entrez:
8
9
2024
Statut:
ppublish
Résumé
Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.
Substances chimiques
Antifungal Agents
0
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13785Subventions
Organisme : National Key Research Development Program of China
ID : 2022YFC2504804
Organisme : National Key Research Development Program of China
ID : 2022YFC2504800
Organisme : National Key Research Development Program of China
ID : 2022YFC3601800
Organisme : Jiangsu Provincial Medical Key Laboratory, Jiangsu Province Capability Improvement Project through Science, Technology and Education
ID : ZDXYS202204
Informations de copyright
© 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.
Références
Lockhart SR, Chowdhary A, Gold J. The rapid emergence of antifungal‐resistant human‐pathogenic fungi. Nat Rev Microbiol. 2023;21(12):818‐832. doi:10.1038/s41579-023-00960-9
Bishnoi A, Vinay K, Dogra S. emergence of recalcitrant dermatophytosis in India. Lancet Infect Dis. 2018;18(3):250‐251. doi:10.1016/s1473-3099(18)30079-3
Kong X, Song G, Mei H, et al. The domestic isolation of Terbinafine‐ and Itraconazole‐resistant Trichophyton Indotineae in Chinese Mainland. Mycopathologia. 2023;188(4):383‐393. doi:10.1007/s11046-023-00761-x
Chowdhary A, Singh A, Kaur A, Khurana A. The emergence and worldwide spread of the species Trichophyton indotineae causing difficult‐to‐treat dermatophytosis: a new challenge in the management of dermatophytosis. PLoS Pathog. 2022;18(9):e1010795. doi:10.1371/journal.ppat.1010795
Liu WD, Liang GZ, Li XF, et al. Alarming the prevalence of Trichophyton indotineae in China. Chin J Mycol. 2023;18(4):289‐290. doi:10.3969/j.issn.1673-3827.2023.04.001
Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51(Suppl 4):2‐15. doi:10.1111/j.1439-0507.2008.01606.x
Song G, Zhang M, Liu W, Liang G. Changing face of epidemiology of dermatophytoses in Chinese Mainland: a 30 Years Nationwide Retrospective Study from 1991 to 2020. Mycoses. 2022;65(4):440‐448. doi:10.1111/myc.13425
Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother. 2003;47(1):82‐86. doi:10.1128/aac.47.1.82-86.2003
Hsiao YH, Chen C, Han HS, Kano R. The first report of terbinafine resistance Microsporum canis from a cat. J Vet Med Sci. 2018;80(6):898‐900. doi:10.1292/jvms.17-0680
Salehi Z, Shams‐Ghahfarokhi M, Razzaghi‐Abyaneh M. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine‐resistant isolates. Eur J Clin Microbiol Infect Dis. 2018;37(10):1841‐1846. doi:10.1007/s10096-018-3317-4
Rezaei‐Matehkolaei A, Rafiei A, Makimura K, Gräser Y, Gharghani M, Sadeghi‐Nejad B. Epidemiological aspects of dermatophytosis in Khuzestan, southwestern Iran, an update. Mycopathologia. 2016;181(7–8):547‐553. doi:10.1007/s11046-016-9990-x
Zhu HM, Wen H. Research progress on terbinafine resistant dermatophytes. Chin J Mycol. 2020;15(4):253‐256. doi:10.3969/j.issn.1673-3827.2020.04.017
Yamada T, Maeda M, Alshahni MM, et al. Terbinafine resistance of trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene. Antimicrob Agents Chemother. 2017;61(7):e00115‐e00117. doi:10.1128/aac.00115-17
Kano R, Kimura U, Kakurai M, et al. Trichophyton indotineae sp. nov.: a new highly terbinafine‐resistant anthropophilic dermatophyte species. Mycopathologia. 2020;185(6):947‐958. doi:10.1007/s11046-020-00455-8
Švarcová M, Větrovský T, Kolařík M, Hubka V. Defining the relationship between phylogeny, clinical manifestation, and phenotype for Trichophyton mentagrophytes/interdigitale complex; a literature review and taxonomic recommendations. Med Mycol. 2023;61(5):myad042. doi:10.1093/mmy/myad042
Uhrlass S, Verma SB, Graser Y, et al. Trichophyton indotineae—an emerging pathogen causing recalcitrant dermatophytoses in India and Worldwide—a multidimensional perspective. J Fungi (Basel). 2022;8(7):757. doi:10.3390/jof8070757
Centers for Disease Control and Prevention. The rise of resistant ringworm: genomic sequencing confirms the first two reported U.S. cases of Trichophyton indotineae. 2023 https://www.cdc.gov/amd/whats‐new/tindotineae.html
Mycobank Database, taxon name Trichophyton indotineae. https://www.mycobank.org/Simple%20names%20search
Atlas of clinical fungi. https://www.clinicalfungi.org/page/Atlas%20Online: Trichophyton indotineae.
Zhan P, Liu W. The changing face of dermatophytic infections worldwide. Mycopathologia. 2017;182(1–2):77‐86. doi:10.1007/s11046-016-0082-8
Verma SB, Panda S, Nenoff P, et al. The unprecedented epidemic‐like scenario of dermatophytosis in India: i. Epidemiology, risk factors and clinical features. Indian J Dermatol Venereol Leprol. 2021;87(2):154‐175. doi:10.25259/ijdvl_301_20
Saunte DML, Pereiro‐Ferreirós M, Rodríguez‐Cerdeira C, et al. Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. J Eur Acad Dermatol Venereol. 2021;35(7):1582‐1586. doi:10.1111/jdv.17241
Jabet A, Normand AC, Brun S, et al. Trichophyton indotineae, from epidemiology to therapeutic. J Mycol Med. 2023;33(3):101383. doi:10.1016/j.mycmed.2023.101383
Nenoff P, Verma SB, Ebert A, et al. Spread of terbinafine‐resistant Trichophyton mentagrophytes Type VIII (India) in Germany‐“The tip of the Iceberg?”. J Fungi (Basel). 2020;6(4):207. doi:10.3390/jof6040207
Jabet A, Brun S, Normand AC, et al. extensive dermatophytosis caused by terbinafine‐resistant Trichophyton indotineae. France Emerg Infect dis. 2022;28(1):229‐233. doi:10.3201/eid2801.210883
Jia S, Long X, Hu W, et al. the epidemic of the multiresistant dermatophyte Trichophyton indotineae has reached China. Front Immunol. 2022;13:1113065. doi:10.3389/fimmu.2022.1113065
Xie W, Kong X, Zheng H, et al. Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug‐resistant Trichophyton indotineae in China. Br J Dermatol. 2024;190(4):585‐587. doi:10.1093/bjd/ljae009
Gupta AK, Venkataraman M, Hall DC, Cooper EA, Summerbell RC. The emergence of Trichophyton indotineae: implications for clinical practice. Int J Dermatol. 2023;62(7):857‐861. doi:10.1111/ijd.16362
Khurana A, Masih A, Chowdhary A, et al. Correlation of in vitro susceptibility based on mics and squalene epoxidase mutations with clinical response to terbinafine in patients with tinea corporis/cruris. Antimicrob Agents Chemother. 2018;62(12):e01038‐18. doi:10.1128/aac.01038-18
Khurana A, Gupta A, Sardana K, et al. A prospective study on patterns of topical steroids self‐use in dermatophytoses and determinants predictive of cutaneous side effects. Dermatol Ther. 2020;33(4):e13633. doi:10.1111/dth.13633
Ebert A, Monod M, Salamin K, et al. Alarming India‐wide phenomenon of antifungal resistance in dermatophytes: a multicentre study. Mycoses. 2020;63(7):717‐728. doi:10.1111/myc.13091
Saunte DML, Hare RK, Jørgensen KM, et al. Emerging terbinafine resistance in Trichophyton: clinical characteristics, squalene epoxidase gene mutations, and a reliable EUCAST Method for detection. Antimicrob Agents Chemother. 2019;63(10):e01126‐19. doi:10.1128/aac.01126-19
Firooz A, Lotfali E, Fattahi M, Fattahi M, Miramin Mohammadi A, Shahrzad Kavkani M. A case of terbinafine‐resistant tinea cruris caused by Trichophyton tonsurans. Case Rep Dermatol Med. 2021;2021:9611072. doi:10.1155/2021/9611072
Gupta AK, Williams JV, Zaman M, Singh J. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients. Med Mycol. 2009;47(8):796‐801. doi:10.3109/13693780802712523
The Mycology Group of the Dermatology and Venereology Branch of the Chinese Medical Association. Diagnosis and treatment guidelines for tinea corporis and cruris (2008 edition). Chin J Dermatol. 2009;42(2):75. doi:10.3760/cma.j.issn.0412-4030.2009.02.001
Hui D, Xue‐Cheng S, Ai‐E X. Evaluation of reflectance confocal microscopy in dermatophytosis. Mycoses. 2013;56(2):130‐133. doi:10.1111/j.1439-0507.2012.02222.x
Tang C, Kong X, Ahmed SA, et al. Taxonomy of the Trichophyton mentagrophytes/T. Interdigitale species complex harboring the highly virulent, multiresistant genotype T. Indotineae. Mycopathologia. 2021;186(3):315‐326. doi:10.1007/s11046-021-00544-2
Tang C, Ahmed SA, Deng S, et al. Detection of emerging genotypes in Trichophyton Mentagrophytes species complex: a proposal for handling biodiversity in dermatophytes. Front Microbiol. 2022;13:960190. doi:10.3389/fmicb.2022.960190
Normand AC, Moreno‐Sabater A, Jabet A, et al. MALDI‐TOF Mass spectrometry online identification of Trichophyton indotineae using the MSI‐2 Application. J Fungi (Basel). 2022;8(10):1103. doi:10.3390/jof8101103
Dabas Y, Xess I, Singh G, Pandey M, Meena S. molecular identification and antifungal susceptibility patterns of clinical dermatophytes following CLSI and EUCAST guidelines. J Fungi (Basel). 2017;3(2):17. doi:10.3390/jof3020017
Curatolo R, Juricevic N, Leong C, Bosshard PP. antifungal susceptibility testing of dermatophytes: development and evaluation of an optimised broth microdilution method. Mycoses. 2021;64(3):282‐291. doi:10.1111/myc.13202
Shaw D, Singh S, Dogra S, et al. MIC and upper limit of wild‐type distribution for 13 antifungal agents against a Trichophyton mentagrophytes‐Trichophyton interdigitale complex of Indian origin. Antimicrob Agents Chemother. 2020;64(4):e01964‐19. doi:10.1128/aac.01964-19
Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: is the problem deeper than we perceive? Indian Dermatol Online J. 2016;7(2):73‐76. doi:10.4103/2229-5178.178100
Yamada T, Yaguchi T, Maeda M, et al. Gene amplification of CYP51B: a new mechanism of resistance to azole compounds in Trichophyton indotineae. Antimicrob Agents Chemother. 2022;66(6):e0005922. doi:10.1128/aac.00059-22
Kano R, Hsiao YH, Han HS, Chen C, Hasegawa A, Kamata H. Resistance mechanism in a terbinafine‐resistant strain of Microsporum canis. Mycopathologia. 2018;183(3):623‐627. doi:10.1007/s11046-018-0242-0
Monod M, Feuermann M, Salamin K, et al. Trichophyton rubrum azole resistance mediated by a new ABC transporter, TruMDR3. Antimicrob Agents Chemother. 2019;63(11):e00863‐1. doi:10.1128/aac.00863-19
Chinese working group on diagnosis and treatment guidelines for tinea corporis and tinea cruris. Chinese guidelines for diagnosis and treatment of tinea corporis and tinea cruris (Grassroots Practice Edition, 2022). Chin J Mycol. 2022;17(3):177‐182. doi:10.3969/j.issn.1673-3827.2022.03.001
Song G, Kong X, Li X, Liu W, Liang G. Prior selection of itraconazole in the treatment of recalcitrant Trichophyton indotineae infection: real‐world results from retrospective analysis. Mycoses. 2023;67:e13663. doi:10.1111/myc.13663
Singh S, Chandra U, Anchan VN, Verma P, Tilak R. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial. Br J Dermatol. 2020;183(5):840‐846. doi:10.1111/bjd.19146
Singh A, Masih A, Khurana A, et al. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, india harbouring mutations in the squalene epoxidase gene. Mycoses. 2018;61(7):477‐484. doi:10.1111/myc.12772
Noguchi H, Matsumoto T, Hiruma M, et al. Tinea unguium caused by terbinafine‐resistant Trichophyton rubrum successfully treated with fosravuconazole. J Dermatol. 2019;46(12):e446‐e447. doi:10.1111/1346-8138.15033
Babu PR, Pravin AJS, Deshmukh G, Dhoot D, Samant A, Kotak B. Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis. Indian J Dermatol. 2017;62(4):395‐399. doi:10.4103/ijd.IJD_191_17
Fattahi A, Shirvani F, Ayatollahi A, et al. Multidrug‐resistant Trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature. Int J Dermatol. 2021;60(6):686‐692. doi:10.1111/ijd.15226
Rengasamy M, Shenoy MM, Dogra S, et al. Indian Association of dermatologists, venereologists and leprologists (IADVL) task force against recalcitrant tinea (ITART) consensus on the management of glabrous tinea (INTACT). Indian Dermatol Online J. 2020;11(4):502‐519. doi:10.4103/idoj.IDOJ_233_20
Gaurav V, Bhattacharya SN, Sharma N, et al. Terbinafine resistance in dermatophytes: time to revisit alternate antifungal therapy. J Mycol Médicale. 2021;31(1):101087. doi:10.1016/j.mycmed.2020.101087
Hiruma J, Kitagawa H, Noguchi H, et al. Terbinafine‐resistant strain of Trichophyton interdigitale strain isolated from a tinea pedis patient. J Dermatol. 2019;46(4):351‐353. doi:10.1111/1346-8138.14809
Gueneau R, Joannard B, Haddad N, et al. Extensive dermatophytosis caused by terbinafine‐resistant Trichophyton indotineae, successfully treated with topical voriconazole. Int J Antimicrob Agents. 2022;60(5–6):106677. doi:10.1016/j.ijantimicag.2022.106677
Rajagopalan M, Inamadar A, Mittal A, et al. Expert consensus on the management of dermatophytosis in India (ECTODERM India). BMC Dermatol. 2018;18(1):6. doi:10.1186/s12895-018-0073-1
Crotti S, Cruciani D, Spina S, et al. A terbinafine sensitive Trichophyton indotineae strain in Italy: the first clinical case of tinea corporis and onychomycosis. J Fungi (Basel). 2023;9(9):865. doi:10.3390/jof9090865
Moreno‐Sabater A, Normand AC, Bidaud AL, et al. Terbinafine resistance in dermatophytes: a French multicenter prospective study. J Fungi (Basel). 2022;8(3):220. doi:10.3390/jof8030220